These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 6090486)
1. One-step isocratic high-performance liquid chromatographic purification of radioiodinated and radioiodinated-photoactivable derivatives of cholecystokinin. Svoboda M; Lambert M; Moroder L; Christophe J J Chromatogr; 1984 Jul; 296():199-211. PubMed ID: 6090486 [TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of a new cholecystokinin receptor probe that can be oxidatively radioiodinated. Pearson RK; Hadac EM; Miller LJ Gastroenterology; 1986 Jun; 90(6):1985-91. PubMed ID: 3009263 [TBL] [Abstract][Full Text] [Related]
3. Purification of radioiodinated photoactivable glucagon by isocratic high-performance liquid chromatography. Sonnenberg J; Pingoud V J Chromatogr; 1985 Aug; 331(1):133-9. PubMed ID: 4044735 [TBL] [Abstract][Full Text] [Related]
4. A new probe for affinity labelling pancreatic cholecystokinin receptor with minor modification of its structure. Fourmy D; Lopez P; Poirot S; Jimenez J; Dufresne M; Moroder L; Powers SP; Vaysse N Eur J Biochem; 1989 Nov; 185(2):397-403. PubMed ID: 2583188 [TBL] [Abstract][Full Text] [Related]
5. 125I-(Thr34, Nle37)- CCK31-39 a non oxidizable tracer for the characterization of CCK receptor on pancreatic acini and radio-immunoassay of C-terminal CCK peptides. Fourmy D; Pradayrol L; Vaysse N; Susini C; Ribet A J Immunoassay; 1984; 5(1-2):99-120. PubMed ID: 6201510 [TBL] [Abstract][Full Text] [Related]
6. Study of the states and populations of the rat pancreatic cholecystokinin receptor using the full peptide antagonist JMV 179. Silvente Poirot S; Hadjiivanova C; Escrieut C; Dufresne M; Martinez J; Vaysse N; Fourmy D Eur J Biochem; 1993 Mar; 212(2):529-38. PubMed ID: 8444190 [TBL] [Abstract][Full Text] [Related]
7. Preparation of biologically active radioiodinated cholecystokinin for radioreceptor assay and radioimmunoassay. Sankaran H; Deveney CW; Goldfine ID; Williams JA J Biol Chem; 1979 Oct; 254(19):9349-51. PubMed ID: 226515 [TBL] [Abstract][Full Text] [Related]
8. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor. Poirot SS; Escrieut C; Dufresne M; Martinez J; Bouisson M; Vaysse N; Fourmy D Mol Pharmacol; 1994 Apr; 45(4):599-607. PubMed ID: 8183238 [TBL] [Abstract][Full Text] [Related]
9. Discovery of a cholecystokinin analogue with partial agonist activity. Howard JM; Knight M; Jensen RT; Gardner JD Am J Physiol; 1984 Sep; 247(3 Pt 1):G261-4. PubMed ID: 6206732 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological and biochemical characterization of cholecystokinin/gastrin receptors in developing rat pancreas. Age-related expression of distinct receptor glycoforms. Hadjiivanova C; Dufresne M; Poirot S; Sozzani P; Vaysse N; Moroder L; Fourmy D Eur J Biochem; 1992 Feb; 204(1):273-9. PubMed ID: 1740139 [TBL] [Abstract][Full Text] [Related]
12. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33). Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685 [TBL] [Abstract][Full Text] [Related]
13. Solubilization from rat pancreatic plasma membranes of a cholecystokinin (CCK) agonist-receptor complex interacting with guanine nucleotide regulatory proteins coexisting in the same macromolecular system. Lambert M; Svoboda M; Furnelle J; Christophe J Eur J Biochem; 1985 Mar; 147(3):611-7. PubMed ID: 2983985 [TBL] [Abstract][Full Text] [Related]
14. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors. Zhou W; Povoski SP; Bell RH J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864 [TBL] [Abstract][Full Text] [Related]
15. Differential expression of A- and B-subtypes of cholecystokinin/gastrin receptors in the developing calf pancreas. Le Meuth V; Philouze-Rome V; Le Huerou-Luron I; Formal M; Vaysse N; Gespach C; Guilloteau P; Fourmy D Endocrinology; 1993 Sep; 133(3):1182-91. PubMed ID: 8365360 [TBL] [Abstract][Full Text] [Related]
16. Distinct cholecystokinin receptors in brain and pancreas. Innis RB; Snyder SH Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6917-21. PubMed ID: 6256771 [TBL] [Abstract][Full Text] [Related]
17. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas. Povoski SP; Zhou W; Longnecker DS; Bell RH Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527 [TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of a fully active biotinylated probe of cholecystokinin. Izzo RS; Pellecchia C; Weinstein MI; Massimillo AJ Prep Biochem; 1990; 20(3-4):205-17. PubMed ID: 2287607 [TBL] [Abstract][Full Text] [Related]
20. Cyclic cholecystokinin analogues with high selectivity for central receptors. Charpentier B; Pelaprat D; Durieux C; Dor A; Reibaud M; Blanchard JC; Roques BP Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1968-72. PubMed ID: 3162318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]